Final Hours Left to Invest at the Throne’s Equity Crowdfunding Campaign
We sincerely appreciate all our investors who kindly care and support the Throne’s Crowdfunding Campaign at StartEngine, leading to the initiation of our clinical trials of Stem Cell Educator therapy
1 Day Left to Invest at the Throne’s Equity Crowdfunding Campaign
We sincerely appreciate all our investors who kindly care and support the Throne’s Crowdfunding Campaign at StartEngine, leading to the initiation of our clinical trials of Stem Cell Educator therapy. This
7 Days Left to Invest at the Throne’s Equity Crowdfunding Campaign
We are so thankful for all of our investors so far and sincerely appreciate all your generosities to support the clinical trials of Stem Cell Educator therapy to treat type
Throne Biotechnologies Receive Award: One of the “5 Best BioTech Companies To Watch” by The Silicon Review
We are honored to announce that Throne Biotechnologies (Throne) is one of the awardees of the “5 Best BioTech Companies To Watch“ by The Silicon Review.
Why Can Stem Cell Educator Therapy Be Utilized to Treat Type 2 Diabetes?
Type 2 diabetes (T2D) is the most common type of diabetes, with prevalence increasing worldwide due to the popularization of a Western lifestyle characterized by overnutrition and limited exercise. According
Throne Biotechnologies Launch the Equity Crowdfunding
NOW LIVE: We are very excited that our equity crowdfunding campaign is live on Start Engine! The Press Release of this campaign has been widely published in major social media
Throne Launches Equity Crowdfunding
To support the United States FDA-approved phase 2 clinical trials of Stem Cell Educator therapy and find a cure for type 1 diabetes and other autoimmune diseases, we are excited
Dr. Yong Zhao will Give an Oral Presentation at the 13th International Congress on Autoimmunity in Athens
We are delighted to announce that Dr. Yong Zhao, founder and CEO at Throne, will give an oral presentation about the Stem Cell Educator therapy in type 1 diabetes at
Stem Cell Educator Therapy in Type 1 Diabetes: from the Bench to Clinical Trials
Type 1 diabetes (T1D) is an autoimmune disease that causes a deficit of pancreatic islet beta cells. Millions of individuals worldwide have T1D, and its incidence increases during the pandemic
Stem Cell Educator Therapy Retains the Global-Leading Technology for the “Practical Cure” Projects in Type 1 Diabetes
Throne Biotechnologies (Throne) is developing Stem Cell Educator therapy to treat type 1 diabetes (T1D) and other autoimmune/inflammation-associated diseases. T1D is an autoimmune disease that causes a deficit of islet